Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial

Kirsten E. Lyke, Joel V. Chua, Michael Koren, Heather Friberg, Gregory D. Gromowski, Rekha R. Rapaka, Adam T. Waickman, Sudhaunshu Joshi, Kathleen Strauss, Michael K. McCracken, Hernando Gutiérrez-Barbosa, Biraj Shrestha, Christopher Culbertson, Paula J. Bernal, Rafael A. De La Barrera, Jeffrey R. Currier, Richard G. Jarman, Robert Edelman